Patent ID: 11896568
Assignee: UNIVERSITY OF CINCINNATI
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 2:
3. The method according to claim 2, wherein the at least one agent effective for inhibiting MYC signaling is selected from the group consisting of flavopiridol, purvalanol A, SU9516, PHA 767491 HCl, SNS-032, JQ1, SGI-1776, EPZ004777, C464, SAHA, triptolide, nutlin-3a, SB220025, LY294002, VAV-939, LY-411575, VX-680, NSC71948, ABT263, VER-155008, KW-2478, SB 218078, and leflunomide.